Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2008
11/20/2008WO2008121963A3 Compositions and methods for gene silencing
11/20/2008WO2008121825A3 Epidermal growth factor (egf) expression and/or polymorphisms thereof for predicting the risk of developing cancer
11/20/2008WO2008121282A3 Broadly representative antigen sequences and method for selection
11/20/2008WO2008119046A3 Methods and compositions for multiplexing detection of nucleic acid sequences within an array element
11/20/2008WO2008118566A3 Ambient temperature stable chemical/biological reagents on membranes or filters
11/20/2008WO2008115561A3 Biomarkers and methods for determining sensitivity to microtubule-stabilizing agents
11/20/2008WO2008115470A3 Hox-gene expression as a biomarker for igf-1r therapeutics
11/20/2008WO2008112269A3 K-ras mutations and anti-egfr antibody therapy
11/20/2008WO2008109463A3 Red-shifted luciferase
11/20/2008WO2008107134A3 A method for detection of liver cancer, risk of liver cancer, risk of recurrence of liver cancer, malignancy of liver cancer and progression of liver cancer with time by using the methylated cytosine in basp1 gene and/or srd5a2 gene
11/20/2008WO2008107114A3 Control genes for the normalization of gene expression analysis data
11/20/2008WO2008106660A3 Isolated phospholipid-protein particles
11/20/2008WO2008106327A3 Biological indicator for use with vaporous microbial deactivating agents and method for making same
11/20/2008WO2008104794A3 Nucleic acid detection
11/20/2008WO2008103992A3 Capillary-channeled polymer film flow cytometry
11/20/2008WO2008103770A3 Multiplex compositions and methods for quantification of human nuclear dna and human male dna and detection of pcr inhibitors
11/20/2008WO2008098159A3 Genetic marker for risk of cardiovascular disorder
11/20/2008WO2008095152A3 Methods and materials for identifying the origin of a carcinoma of unknown primary origin
11/20/2008WO2008094678A3 A molecular prognostic signature for predicting breast cancer distant metastasis, and uses thereof
11/20/2008WO2008094637A3 Luminescent compounds
11/20/2008WO2008093098A3 Methods for indexing samples and sequencing multiple nucleotide templates
11/20/2008WO2008091948A3 Galectin-3-binding, protein as a biomarker of cardiovascular disease
11/20/2008WO2008089281A3 Methods of treating diabetes
11/20/2008WO2008089108A3 Sire early selection for male fertility using single nucleotide polymorphisms (snps) of the dazl gene
11/20/2008WO2008088893A3 Gene polymorphisms in vegf and vegf receptor 2 as markers for cancer therapy
11/20/2008WO2008088876A3 Tissue factor promoter polymorphisms
11/20/2008WO2008083198A3 Genetic markers for orobanche resistance in sunflower
11/20/2008WO2008079877A3 Compositions and methods for the diagnosis and treatment of iron-related disorders
11/20/2008WO2008076375A3 Concurrent analysis of multiple patient samples using solid phase addressable multiplex test with high signal-to-noise ratio
11/20/2008WO2008076374A3 Devices and methods of anonymously deconvoluting combined patient samples and combined patient assays
11/20/2008WO2008070862A3 Non-invasive prenatal genetic screen
11/20/2008WO2008070314A3 Fingerprint analysis for a plurality of oligonucleotides
11/20/2008WO2008070296A3 System and method for diagnosis and treatment of neuropsychiatric disorders
11/20/2008WO2008069940A3 Multi-microrna methods and compositions
11/20/2008WO2008067459A3 Single nucleotide polymorphisms associated with amyotrophic lateral sclerosis
11/20/2008WO2008067408A3 Method of isolating and propagating stem cells from benign tumors
11/20/2008WO2008067069A3 Mitogen activated protein kinase phosphatase 4 (mkp4) and methods of use thereof
11/20/2008WO2008064299A3 Methods of reducing porcine circovirus-associated disease outbreaks
11/20/2008WO2008057537A3 System and method for identifying erythropoietin-responsive genes
11/20/2008WO2008055225A3 Systems and methods for in vivo measurement of interstitial biological activity, processes and/or compositions
11/20/2008WO2008053358A3 A common gene expression signature in dilated cardiomyopathy
11/20/2008WO2008048334A3 Materials and methods for the detection of anthrax related toxin genes
11/20/2008WO2008036929A3 Complex for transferring an anionic substance into a cell
11/20/2008WO2008034129A3 Treatment of cancer or obesity with conjugated linoleic acids
11/20/2008WO2008033866A3 Methods and compositions for the use of lysine riboswitches
11/20/2008WO2008031041A3 Melanoma gene signature
11/20/2008WO2008030605A3 Herv group ii viruses in lymphoma and cancer
11/20/2008WO2008027256A3 Arthritis-associated b cell gene expression
11/20/2008WO2008024902A3 Targeting of fructokinase as therapy for cardiovascular disease, metabolic syndrome, and renal disease
11/20/2008WO2008022022A3 Leptin and growth hormone receptor gene markers associated with rearing, carcass traits and productive life in cattle
11/20/2008WO2008019395A3 Compounds for improving learning and memory
11/20/2008WO2008019324A3 Method for detecting fluorescent signals in a biological sample
11/20/2008WO2008013985A3 Use of heat shock activators for tissue regeneration
11/20/2008WO2008011170A3 Methods for detecting the presence of expanded cgg repeats in the fmr1 gene 5' untranslated region
11/20/2008WO2008008501A3 Reverse restriction fragment length polymorphism assay and uses thereof
11/20/2008WO2008005673A3 Reversible terminator nucleotides and methods of use
11/20/2008WO2008005562A3 Rna silencing compositions and methods for the treatment of huntington's disease
11/20/2008WO2008005281A3 Genes associated with chemotherapy response and uses thereof
11/20/2008WO2008002920A3 Methods for generating target nucleic acid sequences
11/20/2008WO2008002656A3 Methods and materials for in vitro analysis and/or use of membrane-associated proteins, portions thereof or variants thereof
11/20/2008WO2007150069A3 Dpyd gene variants and use thereof
11/20/2008WO2007149870A3 Two-color fluorescent reporter for alternative pre-mrna splicing
11/20/2008WO2007145992A3 Genetic basis of treatment response in depression patients
11/20/2008WO2007143578A3 Perforin-2 proteins
11/20/2008WO2007143037A3 Gene methylation in cancer diagnosis
11/20/2008WO2007142763A3 Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
11/20/2008WO2007131071A3 Mig-7 as a specific anticancer target
11/20/2008WO2007123661A3 Treatment of tumors expressing mutant egf receptors
11/20/2008WO2007120843A3 Single nucleotide polymorphism detection from unamplified genomic dna
11/20/2008WO2007120541A3 Method for cloning and expression of nrui restriction endonuclease
11/20/2008WO2007115205A3 Improved methods, systems and compositions for monitoring enzyme activity and applications thereof
11/20/2008WO2007115068A3 Genetic variants in the indoleamine 2,3-dioxygenase gene
11/20/2008WO2007109781A3 Targeting bacterial suicide pathways for the development of novel antibiotics
11/20/2008WO2007109026A3 Pten compositions and methods for detecting breast cancer
11/20/2008WO2007098379A3 Methods of extracting nucleic acids
11/20/2008WO2007014138A3 Nanoparticles for manipulation of biopolymers and methods thereof
11/20/2008WO2006130829A3 Altered zdhhc8 expression as a marker of increased risk of schizophrenia
11/20/2008WO2006062647A3 Gene expression and genetic changes implicated in alcoholism
11/20/2008WO2005089527A3 Lytic enzymes and spore surface antigen for detection and treatment of bacillus anthracis bacteria and spores
11/20/2008US20080289060 Herbicide tolerant rice plants and methods for identifying same
11/20/2008US20080289057 Sperm factor sequences
11/20/2008US20080289056 Aldolases, nucleic acids encoding them; improving thermal stability of enzyme; biosynthesis of atorvastatin, rosuvastatin, fluvastatin starting from e.g. acetaldehyde and chloroacetaldehyde, using enzyme 2-deoxyribose-5-phosphate aldolase (DERA) to form pyran intermediate
11/20/2008US20080289055 Melanoma antigens and their use in diagnostic and therapeutic methods
11/20/2008US20080289054 Fish Cancer Model
11/20/2008US20080288528 Systems and methods for detecting toxins in a sample
11/20/2008US20080288177 Pharacogenetic method for prediction of the efficacy of methotrexate monotherapy in recent-onset arthritis
11/20/2008US20080288174 Method for Identifying the Function of a Gene
11/20/2008US20080287760 method of making an electrochemical sensor
11/20/2008US20080287759 method of making an electrochemical sensor
11/20/2008US20080287495 Novel benzo[d][1,3]-dioxol derivatives
11/20/2008US20080287388 Human G-Protein Coupled Receptor
11/20/2008US20080287386 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
11/20/2008US20080287384 Methods of Identifying Agents Having Antiangiogenic Activity
11/20/2008US20080287353 Peptides and proteins for early liver development and antibodies thereto
11/20/2008US20080287345 Polymyxin derivatives and uses thereof
11/20/2008US20080287342 Compositions Comprising Modified Collagen and Uses Therefor
11/20/2008US20080287318 Primers and Probes for Detecting Genital Hpv Genotypes
11/20/2008US20080287317 Yeast arrays, methods of making such arrays, and methods of analyzing such arrays
11/20/2008US20080287315 Compositions & methods for monitoring and altering protein folding and solubility
11/20/2008US20080287306 Methods and devices for sequencing nucleic acids
1 ... 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 ... 3003